Published in J Pain Symptom Manage on October 01, 1999
Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol (2008) 2.38
Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer (2005) 2.08
Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol (2011) 2.05
Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer (2004) 1.56
Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage (2004) 1.48
Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun (2007) 1.42
The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs (2009) 1.41
Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal (2011) 1.34
Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome. Cancer Biol Ther (2011) 1.32
Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol (2014) 1.29
Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol (2004) 1.23
The Fatigue Symptom Inventory: a systematic review of its psychometric properties. Support Care Cancer (2010) 1.16
Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. J Pain Symptom Manage (2008) 1.12
Ecological momentary assessment of fatigue following breast cancer treatment. J Behav Med (2004) 1.10
Severe fatigue and related factors in cancer patients before the initiation of treatment. Br J Cancer (2008) 1.09
Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med (2010) 1.07
The relationship between fatigue and light exposure during chemotherapy. Support Care Cancer (2005) 1.07
Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes. Ann Behav Med (2011) 1.07
Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs (2008) 1.05
Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life. BMC Health Serv Res (2009) 0.95
Fatigue and herpesvirus latency in women newly diagnosed with breast cancer. Brain Behav Immun (2011) 0.93
Factors predicting fatigue in breast cancer patients. Support Care Cancer (2003) 0.93
Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer. J Pain Symptom Manage (2012) 0.91
Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance. Support Care Cancer (2012) 0.91
Fatigued breast cancer survivors: the role of sleep quality, depressed mood, stage and age. Psychol Health (2009) 0.90
Personality and fatigue in patients with benign or malignant breast disease. Support Care Cancer (2007) 0.89
The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle. Free Radic Biol Med (2013) 0.88
Validation of the Portuguese version of functional assessment of cancer therapy-fatigue (FACT-F) in Brazilian cancer patients. Support Care Cancer (2009) 0.88
Exploring the Needs and Concerns of Women with Early Breast Cancer during Chemotherapy: Valued Outcomes during a Course of Traditional Acupuncture. Evid Based Complement Alternat Med (2013) 0.87
Conducting routine fatigue assessments for use in clinical oncology practice: patient and provider perspectives. Support Care Cancer (2007) 0.86
Predictors of the intensity of symptoms in a cluster in patients with breast cancer. J Nurs Scholarsh (2009) 0.86
Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma. Cancer Nurs (2011) 0.86
TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness. Am J Physiol Lung Cell Mol Physiol (2010) 0.85
A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. J Support Oncol (2013) 0.85
Association of catastrophizing and fatigue: a systematic review. J Psychosom Res (2012) 0.85
Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy. Oncologist (2012) 0.84
Fatigue patterns and correlates in male liver cancer patients receiving transcatheter hepatic arterial chemoembolization. Support Care Cancer (2004) 0.84
Predicting survival in prostate cancer: the role of quality of life assessment. Support Care Cancer (2011) 0.83
Correction of Low Vitamin D Improves Fatigue: Effect of Correction of Low Vitamin D in Fatigue Study (EViDiF Study). N Am J Med Sci (2014) 0.82
Fatigue in breast cancer patients on adjuvant treatment: course and prevalence. Indian J Palliat Care (2012) 0.82
Symptom clusters in adults with chronic health problems and cancer as a comorbidity. Oncol Nurs Forum (2008) 0.81
Low heart rate variability and cancer-related fatigue in breast cancer survivors. Psychoneuroendocrinology (2014) 0.81
Pilot study of cranial stimulation for symptom management in breast cancer. Oncol Nurs Forum (2010) 0.80
Correspondence between daily and weekly fatigue reports in breast cancer survivors. J Behav Med (2006) 0.80
Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy. J Psychosom Res (2011) 0.79
Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy. Health Psychol (2013) 0.79
A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. J Cancer Surviv (2015) 0.79
Relationship of exercise to quality of life in cancer patients beginning chemotherapy. J Pain Symptom Manage (2011) 0.79
Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine. Cancer Biol Ther (2014) 0.79
Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study. Support Care Cancer (2013) 0.78
Considerations for Training Cancer Survivors. Strength Cond J (2009) 0.77
Fatigue in gynaecological cancer patients: a pilot study. Support Care Cancer (2005) 0.77
An exploration of men's experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol. BMC Cancer (2016) 0.77
Identification of distinct fatigue trajectories in patients with breast cancer undergoing adjuvant chemotherapy. Support Care Cancer (2015) 0.76
Factors associated with fatigue after surgery in women with early-stage invasive breast cancer. Oncologist (2013) 0.76
Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer. Cancer Nurs (2015) 0.76
Randomized sham controlled trial of cranial microcurrent stimulation for symptoms of depression, anxiety, pain, fatigue and sleep disturbances in women receiving chemotherapy for early-stage breast cancer. Springerplus (2015) 0.76
Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer. Psychoneuroendocrinology (2017) 0.75
Fatigue and Quality of Life Outcomes of Palliative Care Consultation: A Prospective, Observational Study in a Tertiary Cancer Center. Indian J Palliat Care (2016) 0.75
Art therapy using famous painting appreciation maintains fatigue levels during radiotherapy in cancer patients. Radiat Oncol J (2016) 0.75
Targeted overexpression of mitochondrial catalase protects against cancer chemotherapy-induced skeletal muscle dysfunction. Am J Physiol Endocrinol Metab (2016) 0.75
Changes in daily activities of cancer patients after diagnosis: how do canadian and Iranian patients perceive the change? Iran J Cancer Prev (2014) 0.75
Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study. Support Care Cancer (2016) 0.75
AT2 receptor: Its role in obesity associated hypertension. Int J Clin Pharmacol Toxicol (2012) 0.75
Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01). Support Care Cancer (2015) 0.75
Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments. Semin Oncol Nurs (2016) 0.75
Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis. Support Care Cancer (2017) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst (1993) 7.87
The uncertainty principle and industry-sponsored research. Lancet (2000) 7.75
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer (2010) 4.95
Environmental tobacco smoke and lung cancer risk in nonsmoking women. J Natl Cancer Inst (1992) 4.19
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Comorbidity and functional status are independent in older cancer patients. J Clin Oncol (1998) 4.11
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer (2006) 3.78
Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res (1998) 3.71
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci U S A (1988) 3.23
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost (2007) 3.22
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
A multidimensional measure of fatigue for use with cancer patients. Cancer Pract (1998) 2.84
Choice of anaesthetic and healthcare facility for third molar surgery. Br J Oral Maxillofac Surg (1998) 2.77
Estimated effect of breast self-examination and routine physician examinations on breast-cancer mortality. N Engl J Med (1978) 2.60
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology (1997) 2.60
Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat (1998) 2.28
Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol (1998) 2.27
Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia. Transfusion (1993) 2.04
RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J (1996) 2.02
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys (1993) 1.99
Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients. Cancer (2001) 1.96
Abdominal obesity and breast cancer risk. Ann Intern Med (1990) 1.83
Control of geohelminths by delivery of targeted chemotherapy through schools. Trans R Soc Trop Med Hyg (1990) 1.77
Chronic community violence: what is happening to our children? Psychiatry (1993) 1.76
The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today (1999) 1.72
Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. MedGenMed (2000) 1.71
Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA (1994) 1.64
Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol (1998) 1.64
Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis (2001) 1.60
Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation. Nature (1976) 1.59
Granular cell tumor. Clinical spectrum of the benign and malignant entity. Cancer (1987) 1.58
The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg (2001) 1.53
Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy. J Natl Cancer Inst (1993) 1.50
Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am (1999) 1.48
Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival? Int J Radiat Oncol Biol Phys (1989) 1.47
Current management of breast cancer. Am Fam Physician (1996) 1.47
Obesity and body fat distribution and breast cancer prognosis. Cancer (1991) 1.46
Intracavitary bleomycin in the management of malignant effusions. Cancer (1976) 1.45
The repetition of parasuicide: a comparison of three cohorts. Br J Psychiatry (1974) 1.42
The survival of Class V restorations in general dental practice: part 3, five-year survival. Br Dent J (2012) 1.42
Operative exposure and management of the petrous and upper cervical internal carotid artery. Neurosurgery (1986) 1.40
Overestimation of test effects in clinical judgment. J Cancer Educ (1993) 1.40
Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost (2014) 1.39
The survival of Class V restorations in general dental practice. Part 2, early failure. Br Dent J (2011) 1.39
CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg (1982) 1.38
Postoperative pain relief; a new approach: narcotics compared with non-steroidal anti-inflammatory drugs. Ann R Coll Surg Engl (1989) 1.38
Multi-disciplinary approach to cranial base tumors. J S C Med Assoc (1994) 1.37
Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat (2000) 1.33
Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol (2000) 1.31
The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med (1971) 1.30
Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosom Med (1998) 1.26
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J Infect Dis (1999) 1.26
The effect of changing disease risk on clinical reasoning. J Gen Intern Med (1994) 1.23
The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial. Diabetologia (2010) 1.23
Clinical features of tumor metastasis to the pituitary. Cancer (1970) 1.22
Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors. J Clin Oncol (1985) 1.22
Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes. Eur J Immunol (1976) 1.20
Follow-up of breast cancer patients. Cancer (1984) 1.20
The economics of febrile neutropenia: implications for the use of colony-stimulating factors. Eur J Cancer (1998) 1.19
Validity and reliability of the FACT-G scale for use in the older person with cancer. Am J Clin Oncol (2001) 1.19
Polymyxin B, colistin, and sodium colistimethate. Med Clin North Am (1982) 1.18
Comparison of spine motion in elite golfers with and without low back pain. J Sports Sci (2002) 1.18
Impact of smoking and smokeless tobacco on the risk of cancer of the head and neck. Head Neck Surg (1987) 1.17
Symptom structure of PTSD following breast cancer. J Trauma Stress (2000) 1.16
The importance of splenic blood flow in clearing pneumococcal organisms. Ann Surg (1982) 1.15
Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer (2002) 1.10
Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial. J Infect Dis (1998) 1.10
Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol (1983) 1.10
Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet (2000) 1.09
The perichondrium plays an important role in mediating the effects of TGF-beta1 on endochondral bone formation. Dev Dyn (2001) 1.09
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol (1992) 1.09
Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study. Cancer Treat Rep (1982) 1.08
Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis (1993) 1.08
Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer. Support Care Cancer (1997) 1.08
Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study. Gut (1983) 1.07
Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res (1973) 1.07
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. AIDS (2000) 1.07
Association of leukemia with radium groundwater contamination. JAMA (1985) 1.06
Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom Manage (2000) 1.05
What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol (2000) 1.02
Validity of a telephone-administered 24-hour dietary recall in telephone and non-telephone households in the rural Lower Mississippi Delta region. J Am Diet Assoc (2001) 1.02
Use of the fluorochrome benzothiocarboxypurine in malaria diagnosis. Trans R Soc Trop Med Hyg (1992) 1.01
Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer (1991) 1.00
A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma. Cancer (1982) 1.00
The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. N Engl J Med (1980) 0.99